Number of participants continent after treatment · people with stroke and urinary incontinence
Complementary therapy interventions may leads to higher number of participants continent after treatment compared with usual care or no treatment (low certainty).
1 finding from 1 review
Number of incontinent episodes · people with stroke and urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Perception of improvement or cure · people with stroke and urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health status and quality of life · people with stroke and urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Functional ability · people with stroke and urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · people with stroke and urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Short‐term abstinence from smoking (< 6 months) · Adult smokers
Interventions to increase adherence showed no clear difference in short‐term abstinence from smoking (< 6 months) compared with standard care (low certainty).
1 finding from 1 review
Abstinence · Adult smokers
Interventions to increase adherence showed no clear difference in long‐term abstinence from smoking (≥ 6 months) compared with standard care (low certainty).
1 finding from 1 review
Proportion of participants at work in the extended long term (≥ 5 years) · patients with coronary heart disease
Physical conditioning interventions may leads to higher proportion of participants at work in the extended long term (≥ 5… compared with usual care (low certainty).
1 finding from 1 review
Return to work · patients with coronary heart disease
2 findings from 1 review
Cardiac mortality · patients with coronary heart disease
Physical conditioning interventions showed no clear difference in adverse effects: cardiac deaths compared with usual care (moderate certainty).
1 finding from 1 review
Proportion of participants returning to work in the short term (up to 6 months) · patients with coronary heart disease
It is very uncertain whether physical conditioning interventions changes proportion of participants returning to work in the short term (up… compared with usual care (very low certainty).
1 finding from 1 review
Proportion of participants returning to work in the medium term (6 months ‐ 1 year) · patients with coronary heart disease
Physical conditioning interventions showed no clear difference in proportion of participants returning to work in the medium term (6… compared with usual care (low certainty).
1 finding from 1 review
Functional outcomes
Percutaneous vascular interventions showed no clear difference in good functional outcome (mRS score 0‐2) compared with intravenous thrombolytic treatment (low certainty).
1 finding from 1 review
Death
Percutaneous vascular interventions showed no clear difference in death compared with intravenous thrombolytic treatment (low certainty).
1 finding from 1 review
Symptomatic intracranial haemorrhage at
Percutaneous vascular interventions showed no clear difference in symptomatic intracranial haemorrhage within first 14 days compared with intravenous thrombolytic treatment (low certainty).
1 finding from 1 review
Vascular status (recanalisation rate)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
ADHD symptoms · adults with ADHD (available evidence for participants aged between 25 to 53 years old)
2 findings from 1 review
ADHD symptoms: self‐reported Assessed by: various scales · adults with ADHD (available evidence for participants aged between 25 to 53 years old)
2 findings from 1 review
Incremental cost‐effectiveness · patients with type 1 or 2 diabetes eligible for diabetic retinopathy screening
1 finding from 1 review